Abivax

Sofinnova invests in Abivax to delay cash crunch

The investment extends Abivax’s cash runway out to the middle of 2020, buying the biotech time to find a partner for ABX464.

Nick Paul Taylor Jul 12, 2019 8:42am

Abivax posts ulcerative colitis data, commits to phase 2b

Sep 4, 2018 4:13am

Abivax, buoyed by HIV milestone, leads surge in value of biotech stocks in Paris

Sep 15, 2016 5:40am